01541 宜明昂科－Ｂ
按盤價 
7.400 +0.090 (+1.231%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 13/11/2024 | 北京龍磐健康醫療投資中心(有限合夥) | 1201(L) | -6,251,800(L) | HKD8.720(L) | 13,011,440(L) | 3.73 |
| 13/11/2024 | 余治華 | 1201(L) | -6,251,800(L) | HKD8.720(L) | 13,011,440(L) | 3.73 |
| 24/10/2024 | 上海張科領弋升帆創業投資中心（有限合夥） | 1201(L) | -3,165,000(L) | HKD5.900(L) | 20,909,600(L) | 5.99 |
| 23/10/2024 | 于曉勇 | 1201(L) | -4,061,800(L) | HKD5.750(L) | 27,242,505(L) | 7.81 |
| 21/10/2024 | 上海張科領弋升帆創業投資中心（有限合夥） | 1201(L) | -1,675,400(L) | HKD5.690(L) | 24,074,600(L) | 6.90 |
| 04/10/2024 | 施毅 | 1201(L) | -1,432,200(L) | HKD7.502(L) | 17,237,175(L) | 4.94 |
| 04/10/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -1,432,200(L) | HKD7.502(L) | 17,237,175(L) | 4.94 |
| 02/10/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,000,000(L) | HKD6.000(L) | 20,721,575(L) | 5.94 |
| 02/10/2024 | 施毅 | 1201(L) | -2,000,000(L) | HKD6.000(L) | 20,721,575(L) | 5.94 |
| 30/09/2024 | 于曉勇 | 1706(L) | 31,304,305(L) | 8.97 | ||
| 25/09/2024 | 施毅 | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
| 25/09/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
| 05/09/2024 | Halo Biomedical LP | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
| 05/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
| 05/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
| 05/09/2024 | 田文志 | 1201(L) | -2,655,855(L) | 115,884,090(L) | 33.20 | |
| 04/09/2024 | 田文志 | 1711(L) | -50,269,972(L) | 0(L) | 0.00 | |
| 04/09/2024 | 于曉勇 | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
| 04/09/2024 | 施毅 | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
| 04/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
| 04/09/2024 | Jiaxing Changxian Enterprise Management L.P. (Limited Partnership) (嘉興昶咸企業管理合夥企業(有限合夥)) | 1711(L) | -7,758,630(L) | 0(L) | 0.00 | |
| 04/09/2024 | Ho Yao | 1701(L) | +4,002,918(L) | 16,011,675(L) | 4.59 | |
| 04/09/2024 | LAV Corporate V GP, Ltd. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
| 04/09/2024 | 田文志 | 1711(L) | +50,269,972(L) | 118,539,945(L) | 33.96 | |
| 04/09/2024 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
| 04/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
| 04/09/2024 | Halo Biomedical LP | 1213(L) | 18,000,000(L) | 5.16 | ||
| 04/09/2024 | LAV GP V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
| 04/09/2024 | Jiaxing Changyu Enterprise Management L.P. (Limited Partnership) (嘉興昶宇企業管理合夥企業(有限合夥)) | 1711(L) | -7,419,847(L) | 0(L) | 0.00 | |
| 04/09/2024 | LAV Biosciences Fund V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
| 04/09/2024 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
| 04/09/2024 | 上海張科領弋升帆創業投資中心（有限合夥） | 1113(L) | +25,750,000(L) | 25,750,000(L) | 7.38 | |
| 04/09/2024 | LAV ImmOn Hong Kong Limited | 1213(L) | 12,542,805(L) | 12,542,805(L) | 3.59 | |
| 04/09/2024 | LAV Asset Management (Hong Kong) Limited | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
| 04/09/2024 | 于曉勇 | 1113(L) | +25,750,000(L) | 31,304,305(L) | 8.97 | |
| 04/09/2024 | LAV ImmuneOnco Hong Kong Limited | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
| 04/09/2024 | 上海張科領弋升帆創業投資中心（有限合夥） | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
| 03/09/2024 | 陈飞 | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
| 03/09/2024 | GBA Fund Investment Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
| 03/09/2024 | Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
| 1 2 3 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 19/11/2024 09:50 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
